Metal film substrate generates surface plasmons to amplify fluorescence signals, resolving low signal-to-noise ratios in ACTH measurement.
Targeting ROR1 antigens spares healthy B cells, eliminating immunosuppression from broad-spectrum therapies.
Radiolabeled nanobodies penetrate tumor tissue to detect PD-L1 expression, avoiding invasive biopsies while minimizing radiation exposure.
A method determines antigen immunogenicity by selecting molecules through adsorption and measuring a neutralization titer.
A non-particulate chemiluminescent reagent uses an olefinic compound and metal chelate to generate light signals in aqueous media.
Anti-GPNMB antibodies use high-affinity binding to detect over-expressed proteins in tumors, improving treatment reliability.
GPRC5DxBCMAxCD3 trispecific antibodies overcome antigen loss recurrence by targeting multiple myeloma antigens simultaneously.
Reversible self-assembled monolayers using bola-form amphiphiles create stable membrane mimicking surfaces with lateral mobility.
A urine biomarker panel detects tuberculosis using SAA1, RETN, and RBP4 levels.
Exogenous cell surface protein expression overcomes folding barriers to enable targeted antibody generation against specific receptors.